Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1993 Jul;56(7):771–775. doi: 10.1136/jnnp.56.7.771

The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease.

N Turjanski 1, W Fernandez 1, A J Lees 1
PMCID: PMC1015058  PMID: 8331352

Abstract

The effects of acute levodopa withdrawal were studied in nine patients with levodopa related on-off oscillations. One patient withdrew from the study due to off period confusion and hallucinations. A marked deterioration in motor disability occurred in all patients following overnight withdrawal of levodopa and a further mild delayed deterioration was present over a mean withdrawal period of 44 hours. Patients with more severe disease were able to tolerate levodopa withdrawal for a shorter period of time than those with milder disease severity. The minimum therapeutic dose of subcutaneous apomorphine needed to produce a similar improvement in patients' mobility, before and after several days of drug withdrawal, did not differ, thus providing no clinical evidence for alterations in striatal dopamine receptor sensitivity after acute levodopa withdrawal.

Full text

PDF
771

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brooks D. J., Ibanez V., Sawle G. V., Playford E. D., Quinn N., Mathias C. J., Lees A. J., Marsden C. D., Bannister R., Frackowiak R. S. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography. Ann Neurol. 1992 Feb;31(2):184–192. doi: 10.1002/ana.410310209. [DOI] [PubMed] [Google Scholar]
  2. Direnfeld L. K., Feldman R. G., Alexander M. P., Kelly-Hayes M. Is L-DOPA drug holiday useful? Neurology. 1980 Jul;30(7 Pt 1):785–788. doi: 10.1212/wnl.30.7.785. [DOI] [PubMed] [Google Scholar]
  3. Direnfeld L., Spero L., Marotta J., Seeman P. The L-dopa on-off effect in Parkinson disease: treatment by transient drug withdrawal and dopamine receptor resensitization. Ann Neurol. 1978 Dec;4(6):573–575. doi: 10.1002/ana.410040619. [DOI] [PubMed] [Google Scholar]
  4. Doller H. J., Connor J. D. Changes in neostriatal dopamine concentrations in response to levodopa infusions. J Neurochem. 1980 May;34(5):1264–1269. doi: 10.1111/j.1471-4159.1980.tb09969.x. [DOI] [PubMed] [Google Scholar]
  5. Ezrin-Waters C., Seeman P. L-DOPA reversal of hyperdopaminergic behaviour. Life Sci. 1978 Mar;22(12):1027–1032. doi: 10.1016/0024-3205(78)90271-0. [DOI] [PubMed] [Google Scholar]
  6. Friedman J. H. 'Drug holidays' in the treatment of Parkinson's disease. A brief review. Arch Intern Med. 1985 May;145(5):913–915. [PubMed] [Google Scholar]
  7. Goetz C. G., Tanner C. M., Nausieda P. A. Weekly drug holiday in Parkinson disease. Neurology. 1981 Nov;31(11):1460–1462. doi: 10.1212/wnl.31.11.1460. [DOI] [PubMed] [Google Scholar]
  8. Hughes A. J., Lees A. J., Stern G. M. Apomorphine test to predict dopaminergic responsiveness in parkinsonian syndromes. Lancet. 1990 Jul 7;336(8706):32–34. doi: 10.1016/0140-6736(90)91531-e. [DOI] [PubMed] [Google Scholar]
  9. Klawans H. L., Goetz C. G., Tanner C. M., Nausieda P. A., Weiner W. J. Levodopa-free periods ("drug holidays") in the management of parkinsonism. Adv Neurol. 1983;37:33–43. [PubMed] [Google Scholar]
  10. Koller W. C., Weiner W. J., Perlik S., Nausieda P. A., Goetz C. G., Klawans H. L. Complications of chronic levodopa therapy: long-term efficacy of drug holiday. Neurology. 1981 Apr;31(4):473–476. doi: 10.1212/wnl.31.4.473. [DOI] [PubMed] [Google Scholar]
  11. Lang A. E. Sudden confusion with levodopa withdrawal. Mov Disord. 1987;2(3):223–223. doi: 10.1002/mds.870020310. [DOI] [PubMed] [Google Scholar]
  12. Lee T., Seeman P., Rajput A., Farley I. J., Hornykiewicz O. Receptor basis for dopaminergic supersensitivity in Parkinson's disease. Nature. 1978 May 4;273(5657):59–61. doi: 10.1038/273059a0. [DOI] [PubMed] [Google Scholar]
  13. Leenders K. L., Palmer A. J., Quinn N., Clark J. C., Firnau G., Garnett E. S., Nahmias C., Jones T., Marsden C. D. Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry. 1986 Aug;49(8):853–860. doi: 10.1136/jnnp.49.8.853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. List S. J., Seeman P. Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats. Life Sci. 1979 Apr 16;24(16):1447–1452. doi: 10.1016/0024-3205(79)90027-4. [DOI] [PubMed] [Google Scholar]
  15. Mayeux R., Stern Y., Mulvey K., Cote L. Reappraisal of temporary levodopa withdrawal ("drug holiday") in Parkinson's disease. N Engl J Med. 1985 Sep 19;313(12):724–728. doi: 10.1056/NEJM198509193131204. [DOI] [PubMed] [Google Scholar]
  16. Nissenbaum H., Quinn N. P., Brown R. G., Toone B., Gotham A. M., Marsden C. D. Mood swings associated with the 'on-off' phenomenon in Parkinson's disease. Psychol Med. 1987 Nov;17(4):899–904. doi: 10.1017/s0033291700000702. [DOI] [PubMed] [Google Scholar]
  17. Nutt J. G., Gancher S. T., Woodward W. R. Does an inhibitory action of levodopa contribute to motor fluctuations? Neurology. 1988 Oct;38(10):1553–1557. doi: 10.1212/wnl.38.10.1553. [DOI] [PubMed] [Google Scholar]
  18. Pycock C. J., Marsden C. D. Central deopaminergic receptor supersensitivity and its relevance to Parkinson's disease. J Neurol Sci. 1977 Jan-Feb;31(1):113–121. doi: 10.1016/0022-510x(77)90009-0. [DOI] [PubMed] [Google Scholar]
  19. Rascol O., Senard J. M., Rascol A., Montastruc J. L. Apomorphine test in parkinsonian syndromes. Lancet. 1990 Aug 25;336(8713):518–518. doi: 10.1016/0140-6736(90)92079-w. [DOI] [PubMed] [Google Scholar]
  20. Reches A., Wagner H. R., Jiang D., Jackson V., Fahn S. The effect of chronic L-dopa administration on supersensitive pre- and postsynaptic dopaminergic receptors in rat brain. Life Sci. 1982 Jul 5;31(1):37–44. doi: 10.1016/0024-3205(82)90398-8. [DOI] [PubMed] [Google Scholar]
  21. Reisine T. D., Fields J. Z., Yamamura H. I. Neurotransmitter receptor alterations in Parkinson's disease. Life Sci. 1977 Aug 1;21(3):335–343. doi: 10.1016/0024-3205(77)90514-8. [DOI] [PubMed] [Google Scholar]
  22. Sage J. I., Duvoisin R. C. Sudden onset of confusion with severe exacerbation of parkinsonism during levodopa therapy. Mov Disord. 1986;1(4):267–270. doi: 10.1002/mds.870010406. [DOI] [PubMed] [Google Scholar]
  23. Sechi G. P., Tanda F., Mutani R. Fatal hyperpyrexia after withdrawal of levodopa. Neurology. 1984 Feb;34(2):249–251. doi: 10.1212/wnl.34.2.249. [DOI] [PubMed] [Google Scholar]
  24. Seeman P., Niznik H. B. Dopamine receptors and transporters in Parkinson's disease and schizophrenia. FASEB J. 1990 Jul;4(10):2737–2744. doi: 10.1096/fasebj.4.10.2197154. [DOI] [PubMed] [Google Scholar]
  25. Steiger M. J., Quinn N. P., Toone B., Marsden C. D. Off-period screaming accompanying motor fluctuations in Parkinson's disease. Mov Disord. 1991;6(1):89–90. doi: 10.1002/mds.870060120. [DOI] [PubMed] [Google Scholar]
  26. Suga M. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats. Life Sci. 1980 Sep 8;27(10):877–882. doi: 10.1016/0024-3205(80)90083-1. [DOI] [PubMed] [Google Scholar]
  27. Sweet R. D., Lee J. E., Speigel H. E., McDowell F. Enhanced response to low doses of levodopa after withdrawal from chronic treatment. Neurology. 1972 May;22(5):520–525. doi: 10.1212/wnl.22.5.520. [DOI] [PubMed] [Google Scholar]
  28. Weiner W. J., Koller W. C., Perlik S., Nausieda P. A., Klawans H. L. Drug holiday and management of Parkinson disease. Neurology. 1980 Dec;30(12):1257–1261. doi: 10.1212/wnl.30.12.1257. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES